U.K.’s NICE Endorses Low-Cost Statins To Treat Cardiovascular Disease
This article was originally published in The Pink Sheet Daily
Executive Summary
Recommendations from the cost-effectiveness agency could make 3.3 mil. people in the U.K. eligible for statin therapy.
You may also be interested in...
Experts Weigh In On Zocor "Pharmacy Status" In U.K., Prospects For U.S. Statin Switch
Four experts in cardiovascular medicine participated in interviews with "The Tan Sheet" to discuss the U.K.'s decision to switch Merck's cholesterol-lowering drug simvastatin 10 mg behind-the-counter.
Tarceva Pancreatic Cancer Indication Turned Down In The EU
Roche will consider requesting a re-examination of the negative decision by the Committee for Medicinal Products for Human Use.
Teva To Investigate High-Dose Copaxone
A Phase III trial will compare 40 mg/day glatiramer to the 20 mg/day approved dose.